Abstract
Dendritic cells (DCs) are professional antigen presenting cells (APCs) central to the induction and regulation of immunity. These specialized immune cells can efficiently acquire antigens in the periphery, process them and present them to cells of the adaptive immune system, inducing antigen-specific immunity. DC-based vaccination therapies against cancer are very promising, since DCs are the most powerful T cell activators. The first part of the following chapter discusses dendritic cell biology pertinent to the design of dendritic cell vaccines (Figure 1), the second part focuses on advances in therapeutic DC cancer vaccination (Figure 2).
| Original language | English |
|---|---|
| Title of host publication | General Principles of Tumor Immunotherapy |
| Subtitle of host publication | Basic and Clinical Applications of Tumor Immunology |
| Publisher | Springer Netherlands |
| Pages | 251-274 |
| Number of pages | 24 |
| ISBN (Electronic) | 9781402060878 |
| ISBN (Print) | 9781402060861 |
| DOIs | |
| State | Published - 2008 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Dendritic cell vaccines'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver